# Phase 2C.2: Multi-Mechanism Identifiability Design (CCCP variant)
# Fixes mito-dominant regime by swapping rotenone → CCCP (more stable mito stressor)
# Raises mito baseline hazard 0.15 → 0.40/h to cross event cliff decisively

# Global settings
global:
  seed: 42
  cell_line: "A549"
  total_wells_per_regime: 48
  vessel_type: "384-well"
  working_volume_ml: 50.0
  initial_confluence: 0.0
  initial_count: 50000

# Extended observation window (like 2C.1.3)
timepoints:
  - 0.0
  - 12.0
  - 24.0
  - 48.0
  - 72.0
  - 96.0
  - 120.0

# Metrics (ER stress + mito dysfunction both observable)
metrics:
  - cell_count
  - viability
  - confluence
  - er_stress
  - mito_dysfunction

# Four regimes: ER-dominant, mito-dominant, mixed, control
regimes:
  # Regime A: ER-Dominant (mito low)
  # Purpose: Recover ER mechanism parameters without mito confounding
  # FIX: Add extra low dose to broaden stress covariate support (fix sharpness p recovery)
  er_dominant:
    plate_id_prefix: "PlateA"
    n_wells_per_dose: 10  # 10 wells × 5 doses = 50 total (was 12×4=48)
    doses:
      # Stress-bracketed for ER (targeting S_ER ∈ [0.35, 0.5, 0.6, 0.7, 0.8])
      # Broader support to identify sharpness p
      - compound: "tunicamycin"
        dose_uM: 0.100
        description: "Well below ER threshold (S_ER ~ 0.35, S_mito ~ 0)"
      - compound: "tunicamycin"
        dose_uM: 0.150
        description: "Below ER threshold (S_ER ~ 0.50, S_mito ~ 0)"
      - compound: "tunicamycin"
        dose_uM: 0.197
        description: "At ER threshold (S_ER ~ 0.59, S_mito ~ 0)"
      - compound: "tunicamycin"
        dose_uM: 0.245
        description: "Above ER threshold (S_ER ~ 0.68, S_mito ~ 0)"
      - compound: "tunicamycin"
        dose_uM: 0.300
        description: "Well above ER threshold (S_ER ~ 0.75, S_mito ~ 0)"
    description: "ER-dominant regime: High ER stress, negligible mito dysfunction. Events should attribute to ER."
    expected_mechanism: "er_stress"

  # Regime B: Mito-Dominant (ER low)
  # Purpose: Recover mito mechanism parameters without ER confounding
  # FIX: Swap rotenone → CCCP (more monotone, sustained mito stressor)
  # FIX: Will scout doses after hazard increase
  mito_dominant:
    plate_id_prefix: "PlateB"
    n_wells_per_dose: 12  # 12 wells × 4 doses = 48 total
    doses:
      # PLACEHOLDER: Will replace after CCCP scout
      # Target: S_mito ∈ [0.4, 0.6, 0.7, 0.8] with sustained elevation
      - compound: "CCCP"
        dose_uM: 1.0
        description: "Below mito threshold (TBD after scout)"
      - compound: "CCCP"
        dose_uM: 3.0
        description: "At mito threshold (TBD after scout)"
      - compound: "CCCP"
        dose_uM: 5.0
        description: "Above mito threshold (TBD after scout)"
      - compound: "CCCP"
        dose_uM: 8.0
        description: "Well above mito threshold (TBD after scout)"
    description: "Mito-dominant regime: High mito dysfunction, negligible ER stress. Events should attribute to mito."
    expected_mechanism: "mito"

  # Regime C: Mixed (both mid, held-out test)
  # Purpose: Test mechanism discrimination when both stresses compete
  mixed:
    plate_id_prefix: "PlateC"
    n_wells: 48
    compound_combo:
      - compound: "tunicamycin"
        dose_uM: 0.15  # Mid ER stress (S_ER ~ 0.50)
      - compound: "CCCP"
        dose_uM: 3.0   # Mid mito dysfunction (TBD after scout)
    description: "Mixed regime: Both ER and mito at mid-levels. Tests mechanism competition and attribution."
    expected_mechanism: "mixed"

  # Regime D: Control (RE baseline)
  # Purpose: Phase 1 RE variance (unchanged from 2C.1)
  control:
    plate_id_prefix: "PlateD"
    n_wells: 48
    compound: "dmso"
    dose_uM: 0.0
    description: "Control regime for RE estimation. Both stresses negligible."
    expected_commitments: 0

# Ground truth (BOTH mechanisms enabled)
truth:
  # Phase 1 smooth REs
  phase1:
    enabled: true
    growth_cv: 0.10
    stress_sensitivity_cv: 0.08
    hazard_scale_cv: 0.12
    plate_level_fraction: 0.3

  # Phase 2A ER commitment
  phase2a_er:
    enabled: true
    threshold: 0.60
    baseline_hazard_per_h: 0.20  # Same as 2C.1.3
    sharpness_p: 2.0
    hazard_cap_per_h: 2.0
    committed_death_hazard_per_h: 0.50

  # Phase 2A Mito commitment
  # FIX: Raise baseline hazard 0.15 → 0.40/h to cross event cliff
  phase2a_mito:
    enabled: true
    threshold: 0.60  # Same threshold to test discrimination
    baseline_hazard_per_h: 0.40  # INCREASED from 0.15 (2.67× boost)
    sharpness_p: 2.5  # Slightly different sharpness
    hazard_cap_per_h: 2.0
    committed_death_hazard_per_h: 0.50

# Acceptance criteria for multi-mechanism identifiability
acceptance:
  # Per-mechanism parameter recovery (same as 2C.1)
  recovery:
    threshold_abs_error: 0.10
    sharpness_abs_error: 1.0
    baseline_hazard_log_factor: 3.0

  # Held-out prediction (total commitment fraction)
  prediction:
    commitment_fraction_abs_error: 0.15

  # Mechanism attribution accuracy
  attribution:
    min_accuracy_dominant_regimes: 0.80  # ≥80% correct attribution in A/B
    mechanism_split_abs_error: 0.20      # Within ±0.20 for C mechanism fractions

  # Ablation tests
  ablation:
    max_parameter_change_scrambled_labels: 0.05  # Parameters should not change >5% when labels scrambled
    max_hallucinated_mechanism_fraction: 0.10     # ≤10% false attribution when one mechanism disabled
